ICER’s 2022 “Barriers to Fair Access Assessment” Protocol – Healthcare Economist
icer’s 2022 “barriers to fair access assessment” protocol – healthcare

ICER’s 2022 “Barriers to Fair Access Assessment” Protocol – Healthcare Economist

How does ICER plan to determine whether health plans offer fair access to pharmaceuticals? I summarized their approach last year as outlined in their white paper titled “Cornerstones of ‘Fair’ Drug Coverage: Appropriate Cost-Sharing and Utilization Management Policies for Pharmaceuticals.” Last month, final protocol for their “Barriers to Fair Access Assessment“. While the approach follows their previous protocol and white paper, not all all the criteria in this white paper are being evaluated. Which criteria is ICER evaluating? I have summarized the criteria ICER plans to include and exclude in their “Fair Access” assessment below.

Go to the source link

Check Also

Breaking The Rule Of Drug Pricing In America

Breaking The Rule Of Drug Pricing In America

From 2008 to 2021, the price of prescription medications has increased 20% per year. getty …

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.